Research Article
Pharmacological Preconditioning Improves the Viability and Proangiogenic Paracrine Function of Hydrogel-Encapsulated Mesenchymal Stromal Cells
Figure 6
(a) Celastrol-treated hydrogel-encapsulated Vybrant-stained MSCs display 2.4-fold higher retention compared to vehicle-treated MSC at day 7 (, , ). (b) Representative fluorescence imaging of Vybrant-stained encapsulated MSC at 7 days; blank: hydrogel alone containing no cells; skin: no hydrogel or cells.
(a) |
(b) |